Market Newsdesk

TORONTO, Nov. 12, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Avicanna Inc.

TSX Symbol: AVCN

All Issues: Yes

Reason: Pending News

Halt Time (ET): 4:01 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

VANCOUVER, BC, Nov. 12, 2020 /CNW/ – Trading resumes in:

Company: BRUNSWICK RESOURCES INC.  Formerly BRUNSWICK RESOURCES INC.

TSX-Venture Symbol: BRU.H Formerly BRU

Resumption (ET): 9:30  11/13/2020

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

PALO ALTO, Calif., Nov. 12, 2020 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the following upcoming virtual investor conferences:

• Jefferies Virtual London Healthcare Conference on Tuesday, November 17 at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time)
• Evercore ISI HealthCONx Conference on Thursday, December 3 at 8:20 a.m. Pacific Time (11:20 a.m. Eastern Time)

A live webcast of both presentations will be available on the “Events and Presentations” section of Kodiak’s website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.

About Kodiak Sciences Inc.

Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, we are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak’s discovery engine. Kodiak’s lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including age-related macular degeneration, a leading cause of blindness in elderly patients, and diabetic eye diseases, a leading cause of blindness in working-age patients. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development including KSI-501, our bispecific anti-IL-6/VEGF biopolymer conjugate for the treatment of neovascular retinal diseases with an inflammatory component, and we are expanding our early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA. For more information, please visit www.kodiak.com.

Kodiak®, Kodiak Sciences®, ABC™, ABC Platform™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

View original content:http://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-upcoming-conferences-301172352.html

SOURCE Kodiak Sciences Inc.

NEW YORK, Nov. 12, 2020 /PRNewswire/ — B. Riley Principal Merger Corp. II (NYSE: BMRG, BMRG WS, BMRG.U) (“BMRG” or the “Company”), a special purpose acquisition company sponsored by an affiliate of B. Riley Financial, Inc. (Nasdaq: RILY) (“B. Riley Financial”), today announced that its stockholders have voted in favor of the Company’s proposed initial business combination (the “business combination”) with Eos Energy Storage LLC (“Eos”), a leading manufacturer of safe, reliable, low-cost zinc battery storage systems.

The business combination is expected to close on November 16, 2020, subject to the satisfaction of all closing conditions. Upon the closing of the business combination, the Company will be renamed “Eos Energy Enterprises, Inc.” and the Company will delist its units, shares of common stock and warrants from the New York Stock Exchange. The post-business combination company’s common stock and warrants are expected to begin trading on November 17, 2020 on Nasdaq under ticker symbol “EOSE” and “EOSEW”, respectively.

“We thank our financial partners and stockholders for their support in this transaction” said Dan Shribman, Chief Executive Officer of BMRG and Chief Investment Officer of RILY. “We look forward to Eos’s continued growth during this exciting time in the energy storage market.”

About Eos Energy Storage LLC

At Eos, we are on a mission to accelerate clean energy by deploying stationary storage solutions that can help deliver the reliable and cost-competitive power that the market expects in a safe and environmentally sustainable way. Eos has been pursuing this opportunity since 2008 when it was founded. Eos has more than 10 years of experience in battery storage testing, development, deployment, and operation. The Eos Aurora^® system integrates Eos’ aqueous, Znyth^® technology to provide a safe, scalable, and sustainable alternative to lithium-ion. https://eosenergystorage.com

About B. Riley Principal Merger Corp. II

BMRG was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Forward Looking Statements

Certain statements made in this press release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: the inability of the Company to complete the contemplated business combination with Eos; the inability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, the amount of funds available in the Company’s trust account following any redemptions by the Company stockholders; the ability to meet Nasdaq’s listing standards following the consummation of the transactions contemplated by the proposed business combination; costs related to the proposed business combination; and those factors discussed in the definitive proxy statement filed by the Company in connection with the business combination under the heading “Risk Factors,” and other documents of the Company filed, or to be filed, with the Securities and Exchange Commission. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/b-riley-principal-merger-corp-ii-announces-stockholder-approval-of-business-combination-with-eos-energy-storage-llc-301172368.html

SOURCE B. Riley Principal Merger Corp. II

HAMILTON, Ontario and BOSTON, Nov. 12, 2020 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in a “fireside chat” presentation at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 8:30am EST / 1:30pm GMT. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D., Chief Financial Officer John Crowley, and Chief Medical Officer James O’Leary, M.D.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors and Media” section of the Company’s website at https://ir.fusionpharma.com/events-webcasts. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.  

About Fusion
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion’s lead program, FPI-1434, is currently in a Phase 1 clinical trial.

View original content to download multimedia:http://www.prnewswire.com/news-releases/fusion-pharmaceuticals-to-present-at-the-jefferies-virtual-london-healthcare-conference-301172266.html

SOURCE Fusion Pharmaceuticals Inc.

BALTIMORE, Nov. 12, 2020 /PRNewswire/ — Adams Natural Resources Fund, Inc. (NYSE: PEO) declared today a year-end distribution of $0.43 per share. The total distributions by the Fund for 2020 will be $0.73, including the distributions totaling $0.30 per share made prior to today’s announcement. The annual distribution rate represented by these distributions is 6.1%.

The year-end distribution consists of the following:

• $0.20 per share from 2020 net investment income; and
• $0.23 per share from net capital gains realized during 2020, comprised all of long-term gain.

This marks the 69^th consecutive year that the Fund has paid out capital gains and the 86^th consecutive year it has paid out dividends to its shareholders.

Commenting on the year-end distribution, Mark E. Stoeckle, CEO of Adams Natural Resources Fund, said: “Despite the challenging year in Energy, we are proud to continue our long history of providing a substantial distribution to our shareholders. We are pleased to announce our 2020 distribution rate of 6.1%. This exceeds our commitment to distribute least at 6% of the Fund’s trailing 12-month average month-end market price to shareholders.”

The payable date for the distribution is December 18, 2020, the record date is November 23, 2020, and the ex-dividend date is November 20, 2020. The year-end distribution is payable in stock and/or cash at the option of each shareholder.

Details regarding the annual distribution rates and the Fund’s 6% minimum distribution commitment can be found at adamsfunds.com.

###

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 80 years across many market cycles. The Funds are committed to paying an annual distribution rate of 6% or more, providing reliable income to long-term investors. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

Contact:

Lyn Walther

Director of Shareholder Communications
800.638.2479 | [email protected]  

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/adams-natural-resources-fund-declares-year-end-distribution-meets-its-annual-6-minimum-distribution-rate-commitment-301172367.html

SOURCE Adams Funds

BALTIMORE, Nov. 12, 2020 /PRNewswire/ — Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared today a year-end distribution of $0.88 per share. The total distributions by the Fund for 2020 will be $1.03, including the distributions totaling $0.15 per share made prior to today’s announcement. The annual distribution rate represented by these distributions is 6.8%.

The year-end distribution consists of the following:

• $0.07 per share from 2020 net investment income; and
• $0.81 per share from net capital gains realized during 2020, comprised all of long-term gain.

This marks the 56^th consecutive year that the Fund has paid out capital gains and the 85^th consecutive year it has paid out dividends to its shareholders.

Commenting on the year-end distribution, Mark E. Stoeckle, CEO of Adams Diversified Equity Fund, said: “In what has been a challenging year for everyone, we are proud to continue our long history of providing a substantial distribution to our shareholders. We are pleased to announce our 2020 distribution rate of 6.8%, which exceeds our commitment to distribute at least 6% of the Fund’s trailing 12-month average month-end market price.”

The payable date for the distribution is December 23, 2020, the record date is November 23, 2020, and the ex-dividend date is November 20, 2020. The year-end distribution is payable in stock and/or cash at the option of each shareholder.

Details regarding the annual distribution rates and the Fund’s 6% minimum distribution commitment can be found at adamsfunds.com.

###

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 80 years across many market cycles. The Funds are committed to paying an annual distribution rate of 6% or more, providing reliable income to long-term investors. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

Contact:

Lyn Walther

Director of Shareholder Communications
800.638.2479  │ [email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/adams-diversified-equity-fund-declares-year-end-distribution-exceeds-its-annual-6-minimum-distribution-rate-commitment-301172257.html

SOURCE Adams Funds